tiprankstipranks

Justin Renz Insider Profile

11 Followers
Justin Renz, EVP, CFO & Treas at Karyopharm Therapeutics, holds 291.14K shares in Ardelyx (Ticker: ARDX), holds 23.52K shares in Karyopharm Therapeutics (Ticker: KPTI), holds 250.00K shares in Epirus Biopharma (Ticker: EPRSQ).
tipranks
Justin Renz

Justin Renz
Karyopharm Therapeutics (KPTI)
EVP, CFO & Treas

Ranked #96,972 out of 99,335 Corporate Insiders

Profitable Transactions

40%
6 out of 15 Profitable Transactions

Average Return

-79.50%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$2M
98.73%
1.27%
A breakdown of Justin Renz's holdings

Insider Roles

Ardelyx
(ARDX)
CFO
Karyopharm Therapeutics
(KPTI)
EVP, CFO & Treas
Roles that Justin Renz holds in companies

Most Profitable Insider Trade

Stock:
Ardelyx
(ARDX)
Rating:Informative Sell
Date:May 21, 2021 - May 21, 2022
Return:+90.60%
The most profitable trade made by Justin Renz

Justin Renz's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Karyopharm Therapeutics
Nov 14, 2016
EVP, CFO & Treas
Informative Sell
35.52K
$19.87K
Ardelyx
Nov 22, 2024
CFO
Uninformative Sell
25.20K
$1.55M
EPRSQ
Epirus Biopharma
Feb 12, 2014
Uninformative Buy
$125.00K
List of latest transactions for each holding click on a transaction to see Justin Renz's performance on stock

Justin Renz insider profile FAQ

What is the percentage of profitable transactions made by Justin Renz?
The percentage of profitable transactions made by Justin Renz is 40%.
    What is the average return per transaction made by Justin Renz?
    The average return per transaction made by Justin Renz is -79.50%.
      What stocks does Justin Renz hold?
      Justin Renz holds: KPTI, ARDX, EPRSQ stocks.
        What was Justin Renz’s latest transaction?
        Justin Renz latest transaction was an Uninformative Sell of $25.20K.
          What was Justin Renz's most profitable transaction?
          Justin Renz’s most profitable transaction was an Informative Sell of ARDX stock on May 21, 2021. The return on the trade was 90.60%.
            What is Justin Renz's role in Karyopharm Therapeutics?
            Justin Renz's role in Karyopharm Therapeutics is EVP, CFO & Treas.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.